Company Filing History:
4 out of 33 
1 out of 846 
1 out of 3,687 
Years Active: 2012-2020
Title: The Innovative Contributions of Mark Vaal
Introduction
Mark Vaal is a notable inventor based in Perry Hall, Maryland, with a significant portfolio of six patents. His work primarily focuses on developing small molecule compounds that target critical transcriptional complexes, which have implications in various medical fields.
Latest Patents
Among his latest patents, Vaal has developed small molecule compounds aimed at inhibiting the PBX1-DNA interaction in mammalian cells. This invention is particularly relevant for treating a range of medical conditions, including cancers, developmental disorders, inflammatory disorders, autoimmune diseases, and neuro-degenerative disorders. Additionally, he has created compositions and methods for treating cancer, which involve compounds that inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds.
Career Highlights
Throughout his career, Mark Vaal has worked with prominent companies in the pharmaceutical industry, including Eisai Inc. and Otsuka Pharmaceutical Company, Limited. His contributions to these organizations have been instrumental in advancing research and development in the field of medicinal chemistry.
Collaborations
Mark has collaborated with several professionals in his field, including Bridget Duvall and Dana Victor Ferraris. These partnerships have enhanced his research efforts and contributed to the success of his innovative projects.
Conclusion
Mark Vaal's work exemplifies the impact of innovation in the medical field, particularly through his patents that address critical health issues. His contributions continue to influence the development of new therapeutic strategies.